Travere Therapeutics, Inc. - Common Stock (TVTX)

CUSIP: 89422G107

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+3,019,599
Put/Call ratio
197%
SEC-reported price per share
$8.99
Indexed holders
162
Value change
+$27,493,568
Number of buys
82
Open additional details 1 more signal available
Number of sells
86
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
95,925,423

Security key

89422G107

Report period

Q4 2023

Indexed institutions

162

Top holders

10

Ownership snapshot

Top reported holders of TVTX - Travere Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $68,240,853 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $68.24M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $68.24M
ARMISTICE CAPITAL, LLC $67.05M
Deep Track Capital, LP $65.89M
MACQUARIE GROUP LTD $41.77M
VANGUARD GROUP INC $41.73M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$68,240,853
7,633,205 shares
— 30 Sep 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$67,050,000
7,500,000 shares
— 30 Sep 2023
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$65,887,800
7,370,000 shares
— 30 Sep 2023
MACQUARIE GROUP LTD
13F
Company
13F
—
denominator unverified
$41,766,000
4,671,859 shares
— 30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$41,727,074
4,667,458 shares
— 30 Sep 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$39,293,598
4,395,257 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
162
Shares
85,573,515
Indexed holders
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
166
Q4 2023 indexed holders
162
Indexed holder difference
-4
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .